Cell therapy
The company has a DCGI-approved cell therapy product for knee osteoarthritis that is marketed by Alkem.
Source: LinkedIn company description · Retrieved October 13, 2026
Stempeutics is a regenerative medicine company in Bangalore developing stem-cell therapy platform technology for cardiovascular, immune-mediated and degenerative diseases.
Stempeucel® has market authorization in India to treat critical limb ischemia. The company has a diabetic foot ulcer product in Phase 3 and is conducting a Phase 2 trial for perianal fistula due to Crohn’s disease.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company has a DCGI-approved cell therapy product for knee osteoarthritis that is marketed by Alkem.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 21, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 15, 2026, September 18, 2026, September 19, 2026, September 20, 2026, September 21, 2026, September 26, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.